Heart Test Laboratories, Inc. (HSCS)

NASDAQ: HSCS · IEX Real-Time Price · USD
2.02
+0.21 (11.60%)
At close: Jun 24, 2022 4:00 PM
2.04
+0.02 (0.99%)
Pre-market: Jun 27, 2022 7:01 AM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Year 20202019
Revenue
0.030.06
Revenue Growth (YoY)
-60.11%-
Cost of Revenue
0.010.05
Gross Profit
0.010.02
Selling, General & Admin
0.871.8
Research & Development
1.712.04
Operating Expenses
2.583.84
Operating Income
-2.57-3.82
Interest Expense / Income
0.130
Other Expense / Income
-0.25-0.01
Pretax Income
-2.45-3.81
Net Income
-2.45-3.81
Net Income Common
-2.45-3.81
Shares Outstanding (Basic)
33
Shares Outstanding (Diluted)
33
Shares Change
0.00%-
EPS (Basic)
-0.74-1.15
EPS (Diluted)
-0.74-1.15
Free Cash Flow Per Share
-0.74-1.16
Gross Margin
58.35%27.61%
Operating Margin
-10030.18%-5948.99%
Profit Margin
-9577.29%-5937.99%
Free Cash Flow Margin
-9580.56%-5970.25%
EBITDA
-2.29-3.74
EBITDA Margin
-8928.70%-5834.16%
Depreciation & Amortization
0.030.06
EBIT
-2.32-3.81
EBIT Margin
-9059.98%-5933.61%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).